Health ❯Vaccines ❯COVID-19

Moderna

KP.2 Variant Spikevax KP.2 Booster Vaccine Spikevax Vaccine Regulatory Approval

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

The company plans to resubmit its application later this year following interim results from its Phase 3 flu vaccine trial, expected this summer.

Health Canada Approves Moderna's Updated COVID-19 Vaccine